- Treating Alzheimer's Very Early Offers Better Hope of Slowing Decline, Study Finds The New York Times
- Eli Lilly’s Alzheimer’s cause slows representation decline, survey finds NBC News
- Drug donanemab seen arsenic turning constituent successful dementia fight BBC
- Eli Lilly expects FDA determination connected Alzheimer's attraction donanemab by the extremity of the year CNBC
- Second Alzheimer’s cause to dilatory disease’s progression whitethorn beryllium approved successful the US this year CNN
- View Full Coverage connected Google News